(2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide
C48H65F2N7O4 — CID 159660977
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide
(2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide (PubChem CID 159660977) has the molecular formula C48H65F2N7O4 and a molecular weight of 842.09 g/mol. Its IUPAC name is (2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide.
Molecular Properties
| Compound Name | (2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide |
|---|---|
| PubChem CID | 159660977 |
| Molecular Formula | C48H65F2N7O4 |
| Molecular Weight | 842.09 g/mol |
| Exact Mass | 841.51 |
| IUPAC Name | (2R)-N-[(2S)-1-[(2S)-2-[[2-[3-[[(2S)-1-[(2S,5S)-2-cyclohexyl-5-(methylamino)-4-oxohexanoyl]pyrrolidin-2-yl]methyl]-6-fluoro-1H-indol-2-yl]-5-fluorobenzimidazol-1-yl]methyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-methylbutanamide |
| SMILES | CCC[C@H](NC(=O)[C@H](C)CC)C(=O)N1CCC[C@H]1Cn1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2CCCN2C(=O)[C@@H](CC(=O)[C@H](C)NC)C2CCCCC2)nc2cc(F)ccc21 |
| InChI | InChI=1S/C48H65F2N7O4/c1-6-13-39(54-46(59)29(3)7-2)48(61)56-23-12-17-35(56)28-57-42-21-19-33(50)25-41(42)53-45(57)44-38(36-20-18-32(49)24-40(36)52-44)26-34-16-11-22-55(34)47(60)37(27-43(58)30(4)51-5)31-14-9-8-10-15-31/h18-21,24-25,29-31,34-35,37,39,51-52H,6-17,22-23,26-28H2,1-5H3,(H,54,59)/t29-,30+,34+,35+,37+,39+/m1/s1 |
| InChIKey | NJFGJNVIXIAUSI-MXXUYCRVSA-N |
| XLogP | 8.08 |
| TPSA | 132.43 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 842.09 |
| LogP ≤ 5 | 8.08 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'dyes5A(27)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159660977 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.